Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

To Assess Reactogenicity and Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine, When Co-administered With GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine (Infanrix™ Hexa) at 2, 4 and 6 Months of Age.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00338351
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:25.836226+00:00
Published At
2016-09-28T00:00:00+00:00
Record Updated At
2016-09-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hepatitis A"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-09-28"
protocolSection.identificationModule.nctId
"NCT00338351"
protocolSection.identificationModule.officialTitle
"To Assess Reactogenicity and Immunogenicity of GSK Biologicals\u0027 10-valent Pneumococcal Conjugate Vaccine, When Co-administered With GSK Biologicals\u0027 DTPa-HBV-IPV/Hib Vaccine (Infanrix\u2122 Hexa) at 2, 4 and 6 Months of Age."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hepatitis A (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.